Nxstage Medical INC (NXTM) Holder Pennant Capital Management LLC Has Trimmed Stake as Stock Value Rose

June 17, 2018 - By Vivian Currie

Nxstage Medical, Inc. (NASDAQ:NXTM) LogoInvestors sentiment decreased to 1.1 in 2018 Q1. Its down 0.15, from 1.25 in 2017Q4. It turned negative, as 15 investors sold NXTM shares while 45 reduced holdings. 15 funds opened positions while 51 raised stakes. 48.16 million shares or 0.80% more from 47.78 million shares in 2017Q4 were reported. Ubs Asset Americas Incorporated holds 0% in Nxstage Medical, Inc. (NASDAQ:NXTM) or 48,393 shares. Tiverton Asset Limited Liability reported 14,494 shares. Prelude Capital Mgmt Ltd Liability Corp accumulated 33,842 shares. Ancora Advsr Ltd Liability Co reported 74,991 shares. State Of Wisconsin Invest Board has invested 0.08% in Nxstage Medical, Inc. (NASDAQ:NXTM). Ny State Common Retirement Fund holds 70,600 shares. Sg Americas Secs Ltd, New York-based fund reported 26,576 shares. The New York-based Quantbot Technologies LP has invested 0.02% in Nxstage Medical, Inc. (NASDAQ:NXTM). Ameriprise Financial Inc owns 195,204 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 0% stake. Moreover, Pennant Capital Mgmt Limited Co has 16.81% invested in Nxstage Medical, Inc. (NASDAQ:NXTM). 5,498 are owned by Ameritas Inv Prns Incorporated. Wellington Mgmt Group Ltd Liability Partnership stated it has 0% in Nxstage Medical, Inc. (NASDAQ:NXTM). Legal And General Gru Pcl has invested 0% of its portfolio in Nxstage Medical, Inc. (NASDAQ:NXTM). The New York-based Gamco Investors Et Al has invested 0% in Nxstage Medical, Inc. (NASDAQ:NXTM).

Since January 16, 2018, it had 0 insider purchases, and 2 selling transactions for $172,760 activity.

Alan Fournier decreased its stake in Nxstage Medical Inc (NXTM) by 16.05% based on its latest 2018Q1 regulatory filing with the SEC. Pennant Capital Management Llc sold 281,830 shares as the company’s stock rose 13.63% while stock markets declined. The hedge fund run by Alan Fournier held 1.47M shares of the health care company at the end of 2018Q1, valued at $36.66M, down from 1.76M at the end of the previous reported quarter. Pennant Capital Management Llc who had been investing in Nxstage Medical Inc for a number of months, seems to be less bullish one the $1.89 billion market cap company. The stock decreased 0.42% or $0.12 during the last trading session, reaching $28.36. About 240,190 shares traded. Nxstage Medical, Inc. (NASDAQ:NXTM) has risen 20.76% since June 17, 2017 and is uptrending. It has outperformed by 8.19% the S&P500.

Analysts await Nxstage Medical, Inc. (NASDAQ:NXTM) to report earnings on August, 6. They expect $-0.02 EPS, up 33.33 % or $0.01 from last year’s $-0.03 per share. After $-0.02 actual EPS reported by Nxstage Medical, Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

Nxstage Medical, Inc. (NASDAQ:NXTM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: